What are Seaport Therapeutics 's total assets?

Seaport Therapeutics (SPTX) holds $227.7M in total assets.

How much debt does Seaport Therapeutics have?

Seaport Therapeutics carries $5.3M in total debt against -$115.6M of shareholders' equity, a debt-to-equity ratio of -0.05.

How much cash does Seaport Therapeutics have?

Seaport Therapeutics holds $52.9M in cash and equivalents.

Can Seaport Therapeutics cover its short-term obligations?

Its current ratio is 13.24 — current assets exceed current liabilities.

Where does Seaport Therapeutics 's balance sheet data come from?

Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Seaport Therapeutics SPTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q1 '25
Cash and cash equivalents	$52.91M—	$46.04M—	——
Short-term investments	$129.7M—	$169.94M—	——
Prepaid expenses and other current assets	$5.74M—	$7.25M—	——
Total current assets	$188.34M—	$223.23M—	——
Property and equipment, net	$386K—	$412K—	——
Operating lease right-of-use assets	$5.07M—	$4.81M—	——
Other non-current assets	$3.84M—	$2.88M—	——
Equity method investments	$30.04M—	$17.67M—	——
Total assets	$227.67M—	$249.01M—	——
Accounts payable	$4.79M—	$2.01M—	——
Accrued expenses	$11K—	$7K—	——
Operating lease liabilities, current	$1.6M—	$1.64M—	——
Total current liabilities	$14.22M—	$12.78M—	——
Operating lease liabilities, non-current	$3.74M—	$3.44M—	——
Total liabilities	$17.97M—	$16.23M—	——
Common stock	$1K—	$1K—	——
Additional paid-in capital	$23.83M—	$21.26M—	——
Retained earnings	-$139.52M—	-$114.11M—	——
Accumulated other comprehensive income (loss)	$64K—	$301K—	——
Total stockholders' equity	-$115.62M-220%	-$92.55M-272%	-$36.16M—
Total liabilities and stockholders' equity	$227.67M—	$249.01M—	——
Deferred Tax Assets and Other Non-Current Assets	$3.84M—	$2.88M—	——
Net Investment in Lease	$5.07M—	$4.81M—	——
Investments	$30.04M—	$17.67M—	——
Operating lease right-of-use assets	$5.07M—	$4.81M—	——
Other non-current assets	$3.84M—	$2.88M—	——
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$129.7M—	$169.94M—	——
Operating Lease Right-of-Use Assets in Other Assets	$5.07M—	$4.81M—	——
Software and Technology Licenses, Net	$3.84M—	$2.88M—	——
Accrued liabilities and other current	$7.83M—	$9.13M—	——
Other accrued liabilities	$11K—	$7K—	——
Total debt	$5.34M—	$5.08M—	——
Additional paid-in capital	$23.83M—	$21.26M—	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$1K—	$1K—	——
Cumulative Translation Adjustment	$0—	$0—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Seaport Therapeutics 's total assets?: Seaport Therapeutics (SPTX) holds $227.7M in total assets.
How much debt does Seaport Therapeutics have?: Seaport Therapeutics carries $5.3M in total debt against -$115.6M of shareholders' equity, a debt-to-equity ratio of -0.05.
How much cash does Seaport Therapeutics have?: Seaport Therapeutics holds $52.9M in cash and equivalents.
Can Seaport Therapeutics cover its short-term obligations?: Its current ratio is 13.24 — current assets exceed current liabilities.
Where does Seaport Therapeutics 's balance sheet data come from?: Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.